Skip to main content

Advertisement

SpringerLink
Log in

Hospital to Home with Mechanical Circulatory Support

  • Decompensated Heart Failure (MM Givertz, Section Editor)
  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Mechanical circulatory support (MCS) is becoming the mainstay of therapy for patients with advanced heart failure, both for patients needing support as a bridge to transplantation and for those who require the device as a destination therapy. As more and more devices are implanted, there is a need to address effective discharge planning, arrange appropriate follow-up, anticipate and address complications, and develop strategies for long-term care. In this article, we will discuss issues surrounding discharge and challenges of managing patients with MCS in the outpatient setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.

    Article  PubMed  Google Scholar 

  2. •• Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32(2):141–56. This is a very good paper to review the long term outcomes in patients with MCS enrolled in the INTERMACS registry.

    Article  PubMed  Google Scholar 

  3. Givertz MM. Ventricular Assist Devices. Circulation. 2011.

  4. Slaughter MS, Bostic R, Tong K, Russo M, Rogers JG. Temporal changes in hospital costs for left ventricular assist device implantation. J Card Surg. 2011;26(5):535–41.

    Article  PubMed  Google Scholar 

  5. •• Swetz KM, Freeman MR, AbouEzzeddine OF, Carter KA, Boilson BA, Ottenberg AL, et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc. 2011;86(6):493–500. This is a very good paper that emphasizes the need of shared decision making in DT patients.

    Article  PubMed  Google Scholar 

  6. Smedira NG, Hoercher KJ, Lima B, Mountis MM, Starling RC, Thuita L, et al. Unplanned Hospital Readmissions After HeartMate II Implantation. JACC: Heart Failure. Journal of the American College of Cardiology. 2013;1(1):31–9.

    Google Scholar 

  7. McNallan SM, Singh M, Chamberlain AM, Kane RL, Dunlay SM, Redfield MM, et al. Frailty and Healthcare Utilization Among Patients With Heart Failure in the Community. JACC: Heart Failure. Journal of the American College of Cardiology. 2013;1(2):135–41.

    Google Scholar 

  8. Ravaglia G, Forti P, Lucicesare A, Pisacane N, Rietti E, Patterson C. Development of an easy prognostic score for frailty outcomes in the aged. Age Ageing. 2008;37(2):161–6.

    Article  PubMed  Google Scholar 

  9. Afilalo J, Mottillo S, Eisenberg MJ, Alexander KP, Noiseux N, Perrault LP, et al. Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes. 2012;5(2):222–8.

    Article  PubMed  Google Scholar 

  10. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139(5):9–9.

    Article  Google Scholar 

  11. • Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–51. This is the seminal trial based on which the HeartMate 2 device was approved for DT.

    Article  PubMed  CAS  Google Scholar 

  12. Gordon RJ, Weinberg AD, Pagani FD, Slaughter MS, Pappas PS, Naka Y, et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127(6):691–702.

    Article  PubMed  Google Scholar 

  13. Goldstein DJ, Naftel D, Holman W, Bellumkonda MH, Pamboukian SV, Pagani FD, et al. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transplant. 2012;31(11):1151–7.

    Article  PubMed  Google Scholar 

  14. Park SJS, Milano CAC, Tatooles AJA, Rogers JGJ, Adamson RMR, Steidley DED, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5(2):241–8.

    Article  PubMed  Google Scholar 

  15. Kaan A, Young Q-R, Cockell S, Mackay M. Emotional experiences of caregivers of patients with a ventricular assist device. Prog Transplant. 2010;20(2):142–7.

    PubMed  Google Scholar 

  16. Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, et al. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013;61(2):153–63.

    PubMed  Google Scholar 

  17. Forest SJ, Bello R, Friedmann P, Casazza D, Nucci C, Shin JJ, et al. Readmissions after ventricular assist device: etiologies, patterns, and days out of hospital. Ann Thorac Surg. 2013;95(4):1276–81.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Lavanya Bellumkonda and Daniel Jacoby declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT, 06520, USA

    Lavanya Bellumkonda & Daniel Jacoby

  2. Yale Center for Advanced Heart failure and Transplantation, 333 Cedar Street, PO Box 208017, New Haven, CT, 06520, USA

    Lavanya Bellumkonda

Authors
  1. Lavanya Bellumkonda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Jacoby
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lavanya Bellumkonda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellumkonda, L., Jacoby, D. Hospital to Home with Mechanical Circulatory Support. Curr Heart Fail Rep 10, 212–218 (2013). https://doi.org/10.1007/s11897-013-0143-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-013-0143-y

Keywords

Search

Navigation